The University of Chicago Header Logo

Connection

Michael Bishop to Tumor Lysis Syndrome

Back to Details
This is a "connection" page, showing publications Michael Bishop has written about Tumor Lysis Syndrome.
Michael Bishop
Connection Strength
0.676
Tumor Lysis Syndrome
  1. The evolving world of tumor lysis syndrome. Oncology (Williston Park). 2011 Apr 15; 25(4):378, 380.
    View in: PubMed
    Score: 0.365
  2. Tumour lysis syndrome: new therapeutic strategies and classification. Br J Haematol. 2004 Oct; 127(1):3-11.
    View in: PubMed
    Score: 0.232
  3. Elitek-rasburicase: an effective means to prevent and treat hyperuricemia associated with tumor lysis syndrome, a Meeting Report, Dallas, Texas, January 2002. Leukemia. 2003 Mar; 17(3):499-514.
    View in: PubMed
    Score: 0.052
  4. Donor-derived CD19-targeted T cells cause regression of malignancy persisting after allogeneic hematopoietic stem cell transplantation. Blood. 2013 Dec 12; 122(25):4129-39.
    View in: PubMed
    Score: 0.027
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.